Search results
Analysts Set United Therapeutics Co. (NASDAQ:UTHR) Target Price at $312.22
ETF DAILY NEWS· 5 days agoA number of analysts recently weighed in on UTHR shares. The Goldman Sachs Group increased their price objective on shares of United Therapeutics from $218.00 ...
The 3 Best Medical Device Stocks to Buy in June 2024
InvestorPlace· 5 hours agoMedical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical...
Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) By...
Investing.com· 6 days agoFollowing this transaction, the insider now owns 4,185 shares of the company. United...chronic and...
Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
GuruFocus.com via Yahoo Finance· 2 days agoFollowing...Olian has sold a total of 16,700 shares and has not made any purchases of the company's ...
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
Investor's Business Daily· 6 hours agoThe Relative Strength (RS) Rating for Intra-Cellular Therapies stock entered a new percentile...
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 3 days agoThis investing style is all about taking advantage of upward or downward trends in a stock's price...
10 Health Care Stocks Whale Activity In Today's Session - Community Health Sys (NYSE:CYH),...
Benzinga· 1 day agoThis particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $35.2K , with a price of $1600.0 ...
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Investor's Business Daily· 6 days agoThe upgraded 82 RS Rating means Neurocrine Biosciences stock is among the top 18% overall for price performance over the past year. Neurocrine Biosciences ...